首页> 外文OA文献 >Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

【2h】

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

机译：Canakinumab（ACZ885，一种完全人源的IgG1抗IL-1β单抗）会导致儿科患者伴有氯吡喃相关周期性综合征（CAPS）的持续缓解

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jasmin B Kuemmerle-Deschner; Eduardo Ramos; Norbert Blank; Joachim Roesler; Sandra D Felix; Thomas Jung; Kirstin Stricker; Abhijit Chakraborty; Stacey Tannenbaum; Andrew M Wright; Christiane Rordorf;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) [J] . Jasmin B Kuemmerle-Deschner, Eduardo Ramos, Norbert Blank, Arthritis research & therapy. . 2011,第1期

机译：Canakinumab（ACZ885，一种完全人源的IgG1抗IL-1β单抗）会导致儿科患者伴有氯吡喃相关周期性综合征（CAPS）的持续缓解
2. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1beta mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). [J] . Kuemmerle Deschner JB, Ramos E, Blank N, Arthritis research & therapy. . 2011,第1期

机译：Canakinumab（ACZ885，一种完全的人IgG1抗IL-1beta mAb抗体）可以诱导小儿伴有冻菌素相关性周期性综合征（CAPS）的患者持续缓解。
3. Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study. [J] . Kone Paut I, Kuemmerle Deschner JB, Leslie KS, Arthritis research & therapy. . 2011,第6期

机译：使用canakinumab治疗的伴有氯吡格雷相关周期性综合征的患者，症状持续缓解，健康相关的生活质量得到改善：一项双盲安慰剂对照的随机退出研究的结果。
4. Canakinumab (ACZ885 a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) [O] . Jasmin B Kuemmerle-Deschner, Eduardo Ramos, Norbert Blank, 2011

机译：Canakinumab（ACZ885一种完全人源的IgG1抗IL-1β单抗）会导致儿科患者伴有氯吡喃相关周期性综合征（CAPS）的持续缓解
5. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) [O] . Kuemmerle-Deschner, Jasmin B, Ramos, Eduardo, Blank, Norbert, 2011

机译：Canakinumab（ACZ885，一种完全人源的IgG1抗IL-1β单抗）会导致儿科患者伴有氯吡喃相关周期性综合征（CAPS）的持续缓解

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

著录项

引文网络

相似文献

相关主题

期刊订阅